Informationen:
Fehler:
ID
39196
Beschreibung
A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers; ODM derived from: https://clinicaltrials.gov/show/NCT00923533
Link
https://clinicaltrials.gov/show/NCT00923533
Stichworte
Versionen (1)
- 09.12.19 09.12.19 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
9. Dezember 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Essential Hypertension NCT00923533
Eligibility Essential Hypertension NCT00923533
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Essential Hypertension NCT00923533
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Age
Item
age: 20 - 45 years
boolean
C0001779 (UMLS CUI [1])
Gender
Item
sex: male
boolean
C0079399 (UMLS CUI [1])
Body Weight
Item
body weight: greater than 55 kg
boolean
C0005910 (UMLS CUI [1])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Hypersensitivity Fimasartan | Hydrochlorothiazide allergy
Item
known allergy to fimasartan and hydrochlorothiazide
boolean
C0020517 (UMLS CUI [1,1])
C2825622 (UMLS CUI [1,2])
C0571898 (UMLS CUI [2])
C2825622 (UMLS CUI [1,2])
C0571898 (UMLS CUI [2])
Heart Disease | Hematological Disease
Item
existing cardiac or hematological diseases
boolean
C0018799 (UMLS CUI [1])
C0018939 (UMLS CUI [2])
C0018939 (UMLS CUI [2])
Liver diseases | Kidney Diseases
Item
existing hepatic and renal diseases
boolean
C0023895 (UMLS CUI [1])
C0022658 (UMLS CUI [2])
C0022658 (UMLS CUI [2])
Gastrointestinal Diseases
Item
existing gastrointestinal diseases
boolean
C0017178 (UMLS CUI [1])
Disease Affecting Drug absorption | Disease Affecting Drug metabolism | Chronic disease Affecting Drug absorption | Chronic disease Affecting Drug metabolism
Item
acute or chronic diseases which could affect drug absorption or metabolism
boolean
C0012634 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0678745 (UMLS CUI [1,3])
C0012634 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0683140 (UMLS CUI [2,3])
C0008679 (UMLS CUI [3,1])
C0392760 (UMLS CUI [3,2])
C0678745 (UMLS CUI [3,3])
C0008679 (UMLS CUI [4,1])
C0392760 (UMLS CUI [4,2])
C0683140 (UMLS CUI [4,3])
C0392760 (UMLS CUI [1,2])
C0678745 (UMLS CUI [1,3])
C0012634 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0683140 (UMLS CUI [2,3])
C0008679 (UMLS CUI [3,1])
C0392760 (UMLS CUI [3,2])
C0678745 (UMLS CUI [3,3])
C0008679 (UMLS CUI [4,1])
C0392760 (UMLS CUI [4,2])
C0683140 (UMLS CUI [4,3])
Serious mental illness
Item
history of any serious psychological disorder
boolean
C3841614 (UMLS CUI [1])
Drug screen positive | Alcohol consumption screening Positive
Item
positive drug or alcohol screening
boolean
C0743295 (UMLS CUI [1])
C0420032 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
C0420032 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
Tobacco use Number of cigarettes per day
Item
smokers of 10 or more cigarettes per day 3 month ago
boolean
C0543414 (UMLS CUI [1,1])
C3694146 (UMLS CUI [1,2])
C3694146 (UMLS CUI [1,2])
Study Subject Participation Status | Clinical Trial
Item
participation in a clinical trial during the last 2 months prior to the start of the study
boolean
C2348568 (UMLS CUI [1])
C0008976 (UMLS CUI [2])
C0008976 (UMLS CUI [2])